Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Free Subscription

Articles published in Int J Cardiol

Retrieve available abstracts of 41 articles:
HTML format
Text format

Single Articles

    February 2019
  1. MAZIDI M, Mikhailidis DP, Banach M
    Associations between risk of overall mortality, cause-specific mortality and level of inflammatory factors with extremely low and high high-density lipoprotein cholesterol levels among American adults.
    Int J Cardiol. 2019;276:242-247.
    PubMed     Text format     Abstract available

    January 2019
  2. WANG Z, Wang X, Hao G, Chen Z, et al
    A national study of the prevalence and risk factors associated with peripheral arterial disease from China: The China Hypertension Survey, 2012-2015.
    Int J Cardiol. 2019;275:165-170.
    PubMed     Text format     Abstract available

    November 2018
  3. WANG H, Sun Y
    Further insight into the impact of the NLA guideline, ESC guideline, and AACE/ACE guideline on LDL-cholesterol target achievement: Time to rethink the strategy?
    Int J Cardiol. 2018;271:347.
    PubMed     Text format    

    October 2018
    Impact of statin-ezetimibe combination in chronic kidney disease.
    Int J Cardiol. 2018;268:36-37.
    PubMed     Text format    

  5. BREUKER C, Clement F, Mura T, Macioce V, et al
    Non-achievement of LDL-cholesterol targets in patients with diabetes at very-high cardiovascular risk receiving statin treatment: Incidence and risk factors.
    Int J Cardiol. 2018;268:195-199.
    PubMed     Text format     Abstract available

    September 2018
  6. KUMAR R, Tonkin A, Liew D, Zomer E, et al
    The cost-effectiveness of PCSK9 inhibitors - The Australian healthcare perspective.
    Int J Cardiol. 2018;267:183-187.
    PubMed     Text format     Abstract available

  7. WON KB, Han D, Lee JH, Lee SE, et al
    Impact of optimal glycemic control on the progression of coronary artery calcification in asymptomatic patients with diabetes.
    Int J Cardiol. 2018;266:250-253.
    PubMed     Text format     Abstract available

    August 2018
  8. YAN BP, Chiang FT, Ambegaonkar B, Brudi P, et al
    Low-density lipoprotein cholesterol target achievement in patients surviving an acute coronary syndrome in Hong Kong and Taiwan - findings from the Dyslipidemia International Study II.
    Int J Cardiol. 2018;265:1-5.
    PubMed     Text format     Abstract available

  9. BECKOWSKI M, Gierlotka M, Gasior M, Polonski L, et al
    Risk factors predisposing to acute coronary syndromes in young women </=45years of age.
    Int J Cardiol. 2018;264:165-169.
    PubMed     Text format     Abstract available

    July 2018
  10. LIBERALE L, Carbone F, Bertolotto M, Bonaventura A, et al
    Serum PCSK9 levels predict the occurrence of acute coronary syndromes in patients with severe carotid artery stenosis.
    Int J Cardiol. 2018;263:138-141.
    PubMed     Text format     Abstract available

    June 2018
  11. HERMANN M, Witassek F, Erne P, Radovanovic D, et al
    Referral for cardiac rehabilitation after acute myocardial infarction: Insights from nationwide AMIS Plus registry 2005-2017.
    Int J Cardiol. 2018;261:1-5.
    PubMed     Text format     Abstract available

  12. KUWABARA M, Borghi C, Cicero AFG, Hisatome I, et al
    Elevated serum uric acid increases risks for developing high LDL cholesterol and hypertriglyceridemia: A five-year cohort study in Japan.
    Int J Cardiol. 2018;261:183-188.
    PubMed     Text format     Abstract available

  13. WANG X, Fu Q, Song F, Li W, et al
    Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: Results from a national stroke screening survey.
    Int J Cardiol. 2018 Jun 2. pii: S0167-5273(18)30996.
    PubMed     Text format     Abstract available

  14. ZHANG M, Deng Q, Wang L, Huang Z, et al
    Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults.
    Int J Cardiol. 2018;260:196-203.
    PubMed     Text format     Abstract available

    May 2018
  15. SHIN D, Kongpakpaisarn K, Bohra C
    Trends in the prevalence of metabolic syndrome and its components in the United States 2007-2014.
    Int J Cardiol. 2018;259:216-219.
    PubMed     Text format     Abstract available

    March 2018
  16. FREISINGER E, Malyar NM, Reinecke H, Unrath M, et al
    Low rate of revascularization procedures and poor prognosis particularly in male patients with peripheral artery disease - A propensity score matched analysis.
    Int J Cardiol. 2018;255:188-194.
    PubMed     Text format     Abstract available

  17. CANEPA M, Artom N, Ameri P, Carbone F, et al
    Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia.
    Int J Cardiol. 2018;255:215-220.
    PubMed     Text format    

  18. MACHADO LBM, Silva BLS, Garcia AP, Oliveira RAM, et al
    Ideal cardiovascular health score at the ELSA-Brasil baseline and its association with sociodemographic characteristics.
    Int J Cardiol. 2018;254:333-337.
    PubMed     Text format     Abstract available

  19. FEDELI U, Avossa F, Ferroni E, Schievano E, et al
    Diverging patterns of cardiovascular diseases across immigrant groups in Northern Italy.
    Int J Cardiol. 2018;254:362-367.
    PubMed     Text format     Abstract available

    February 2018
  20. GUPTA R, Singh Y
    Treatment gaps in severe hypercholesterolemia.
    Int J Cardiol. 2018;252:199-200.
    PubMed     Text format    

  21. FAGGIANO P, Pirillo A, Griffo R, Ambrosetti M, et al
    Prevalence and management of familial hypercholesterolemia in patients with coronary artery disease: The heredity survey.
    Int J Cardiol. 2018;252:193-198.
    PubMed     Text format     Abstract available

    November 2017
  22. LIN XL, Liu MH
    Statin and ezetimibe combination therapy: New therapeutic options for lowering Low-Density Lipoprotein Cholesterol.
    Int J Cardiol. 2017;247:49.
    PubMed     Text format    

    March 2017
  23. LEE H, Choi EK, Lee SH, Han KD, et al
    Atrial fibrillation risk in metabolically healthy obesity: A nationwide population-based study.
    Int J Cardiol. 2017 Mar 28. pii: S0167-5273(16)32706.
    PubMed     Text format     Abstract available

    February 2017
  24. DUFOUR R, Bergeron J, Gaudet D, Weiss R, et al
    Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment.
    Int J Cardiol. 2017;228:754-760.
    PubMed     Text format     Abstract available

    January 2017
  25. LIN PY, Lee FY, Wallace CG, Chen KH, et al
    The therapeutic effect of rosuvastatin and propylthiouracil on ameliorating high-cholesterol diet-induced rabbit aortic atherosclerosis and stiffness.
    Int J Cardiol. 2017;227:938-949.
    PubMed     Text format     Abstract available

  26. HU D, Yang Y, Peng DQ
    Increased sortilin and its independent effect on circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) in statin-naive patients with coronary artery disease.
    Int J Cardiol. 2017;227:61-65.
    PubMed     Text format     Abstract available

  27. KISHIMOTO S, Kajikawa M, Maruhashi T, Iwamoto Y, et al
    Endothelial dysfunction and abnormal vascular structure are simultaneously present in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(16)32405.
    PubMed     Text format     Abstract available

    November 2016
  28. KUWABARA M, Niwa K, Nishihara S, Nishi Y, et al
    Hyperuricemia is an independent competing risk factor for atrial fibrillation.
    Int J Cardiol. 2016 Nov 15. pii: S0167-5273(16)32841.
    PubMed     Text format     Abstract available

    August 2016
  29. BAEK YS, Yang PS, Kim TH, Uhm JS, et al
    Delayed recurrence of atrial fibrillation 2years after catheter ablation is associated with metabolic syndrome.
    Int J Cardiol. 2016;223:276-281.
    PubMed     Text format     Abstract available

  30. REYES EB, Ha JW, Firdaus I, Ghazi AM, et al
    Heart failure across Asia: Same healthcare burden but differences in organization of care.
    Int J Cardiol. 2016;223:163-167.
    PubMed     Text format     Abstract available

    July 2016
  31. MENDEZ-BAILON M, Munoz-Rivas N, Jimenez-Garcia R, Esteban-Hernandez J, et al
    Impact of type 2 diabetes mellitus in hospitalizations for atrial fibrillation in Spain (2004-2013).
    Int J Cardiol. 2016;221:688-694.
    PubMed     Text format     Abstract available

    June 2016
  32. SAHINER L, Asil S, Kaya EB, Ozer N, et al
    Percutaneous Implantation of the self-expanding valve Prosthesis a patient with homozygous familial hypercholesterolemia severe aortic stenosis and porcelain aorta.
    Int J Cardiol. 2016;220:661-664.
    PubMed     Text format     Abstract available

  33. XIA SJ, Du X, Li C, Wu JH, et al
    Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study.
    Int J Cardiol. 2016;220:284-289.
    PubMed     Text format     Abstract available

  34. WU AH, Gladden JD, Ahmed M, Ahmed A, et al
    Relation of serum uric acid to cardiovascular disease.
    Int J Cardiol. 2016;213:4-7.
    PubMed     Text format     Abstract available

    May 2016
  35. PLAKHT Y, Gilutz H, Shiyovich A
    Decreased admission serum albumin level is an independent predictor of long-term mortality in hospital survivors of acute myocardial infarction. Soroka Acute Myocardial Infarction II (SAMI-II) project.
    Int J Cardiol. 2016;219:20-24.
    PubMed     Text format     Abstract available

    April 2016
  36. DI MINNO MN, Di Minno A, Ambrosino P, Songia P, et al
    Aortic valve sclerosis as a marker of atherosclerosis: Novel insights from hepatic steatosis.
    Int J Cardiol. 2016;217:1-6.
    PubMed     Text format     Abstract available

    March 2016
  37. MASCITELLI L, Goldstein MR
    Might ezetimibe be considered an expensive placebo?
    Int J Cardiol. 2016;207:48-9.
    PubMed     Text format    

    January 2016
  38. NAKOU ES, Simantirakis EN, Kallergis EM, Skalidis EI, et al
    Long-standing sinus arrest due to the occlusion of sinus node artery during percutaneous coronary intervention: Clinical implications and management.
    Int J Cardiol. 2016;203:432-3.
    PubMed     Text format    

  39. TANG L, Jiang L, Pan XD, Chen PP, et al
    Extremely severe aortic stenosis developed in a young female patient with underdiagnosis of homozygous familial hypercholesterolemia: An 8-year follow-up.
    Int J Cardiol. 2016;207:372-374.
    PubMed     Text format    

  40. ZU L, Ren C, Pan B, Zhou B, et al
    Endothelial microparticles after antihypertensive and lipid-lowering therapy inhibit the adhesion of monocytes to endothelial cells.
    Int J Cardiol. 2016;202:756-9.
    PubMed     Text format    

  41. OIKONOMOU E, Siasos G, Tousoulis D
    Atherogenesis and hyperlipidemia a not straightforward association: We really need a novel biomarker?
    Int J Cardiol. 2016;202:586-8.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.